Seroprevalence of hepatitis B virus infection and seroconvertion to anti-HBsAg in laboratory staff in Goiânia, Goiás

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 38, Issue 2, 2005, Pages 153-156

  Silva, Paula Andréia ^a   Souza Fiaccadori, Fabíola ^a   Tavares Borges, Ana Maria ^a   Silva, Simone Almeida ^a   Daher, Roberto Ruhman ^a   Martins, Regina Maria Bringel ^a   Das Dores De Paula Cardoso, Divina ^a,b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Araujo Jorge Cancer Hospital   (Brazil)

Author keywords

Hepatitis B; Laboratory staff; Seroprevalence; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LABORATORY PERSONNEL; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; VACCINATION;

HEPATITIS B VIRUS;

EID: 17144381259     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822005000200005     Document Type: Article

References (19)

1. Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 18: 57-67, 2000.
2. Azevedo MSP, Cardoso DDP, Martins RMB, Daher RR, Camarota SCT, Barbosa AJ. Rastreamento sorológico para hepatite B em profissionais de saúde na cidade de Goiânia-Goiás. Revista da Sociedade Brasileira de Medicina Tropical 23: 157-162, 1994.
3. Birrer RB, Birrer D, Klavins JV. Hepatocellular carcinoma and hepatitis virus. Annals of Clinical and Laboratory Science 33: 39-54, 2003.
4. Center For Diseases Control And Prevention. Viral Hepatitis. Exposure to blood. What health-care workers need to know. Disponível em: 〈http://www.cdc.gov/ncidod/diseases/hepatitis〉. Acesso em: 05 mar, 2002.
5. Coelho HSM, Artemenko SMT, Martins CN, Carvalho DM, Valente J, Rodrigues EC, Alves LS, Martins MLM. Prevalência da infecção para o vírus da hepatite B na comunidade hospitalar. Revista da Sociedade Brasileira de Medicina Tropical 23: 71-76, 1990.
6. Davis GL. Update on the management of chronic hepatitis B. Reviews in Gastroenterological Disorders 2: 106-115, 2002.
7. Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfusion Medicine 14: 97-103, 2004.
8. Fernandes JV, Braz RFS, Neto FVA, Silva MAD, Costa NFD, Ferreira AM. Prevalência de marcadores sorológicos do virus da hepatite B em trabalhadores do serviço hospitalar. Revista de Saúde Pública 33: 122-128, 1999.
9. Gomes AS, Yoshida CFT, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polimerase chain reaction: evaluation of different primer pairs and conditions. Acta Virologica 40:133-38, 1996.
10. Largura MA, Pacheco M, Largura A. Ausência do HBV-DNA por PCR em Soros de Doadores de Sangue com HBsAg Negativo e Anti-HBc Positivo em Regiâo de Alta Prevalência de Hepatite B. Laes & Haes 125: 106-126, 2000.
11. Lopes CLR, Martins RMB, Teles AS, Silva SA, Maggi PS, Yoshida CFTY. Perfil soroepidemiológico da infecção pelo vírus da hepatite B em profissionais das unidades de hemodiálise de Goiânia-Goiás, Bnisil Central. Revista da Sociedade Brasileira de Medicina Tropical 34: 543-548, 2001.
12. Martínez NT, Burillo JMT, Bermúdez BP, Álvarez JBS. Factures asociados a una respuesta inadecuada a la vacunación contra la hepatitis B em personal sanitario. Revista Espanola de Salud Publica 72: 509-515, 1998.
13. Niel C, Moraes MTB, Gaspar AMC, Yoshida CFT, Gomes SA. Genetic diversity of hepatitis B virus strains isolated in Rio de Janeiro, Brazil. Journal of Medical Virology 44: 180-186, 1994.
14. Silva CO, Azevedo MSP, Soares CMA, Martins RMB, Ramos CH, Daher RR, Cardoso DDP. Seroprevalence of hepatitis B virus infection in individuals with clinical evidence of hepatitis in Goiânia, Goiás. Detection of viral DNA and determination of subtypes. Revista do Instituto de Medicina Tropical de São Paulo 44: 331-334, 2002.
15. Zanalda BC, Manterola AC, Lestrem MD, Frider B, Zocchi GA, Fainboim H, Clua GI, Amor E. Prevalencia del anticuerpo contra el antígeno central del virus de la hepatitis B (anti HBc) em personal hospitalario de Buenos Aires. Boletim Sanitário Panamericano 108: 16-24, 1990.
16. Zanetti AR. Update on hepatitis B vaccination in Italy 10 years after its implementation. Vaccine 19: 2380-2383, 2001.
17. Zuckerman JN. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBS production. Journal of Medical Virology 50: 283-288, 1996.
18. Williams JL, Christensen CJ, McMahon BJ, Bulkow LR, Cagle HH, Mayers JS, Zanis CL, Parkinson AJ, Margolis HS. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine 19: 4081-85, 2001.
19. Wolff M. Occupational accidents with exposure to biological fluids. Recommendations for the management of exposed workers. Revista Medica de Chile 125: 605-613, 1997.